Literature DB >> 34642466

Repression of p53 function by SIRT5-mediated desuccinylation at Lysine 120 in response to DNA damage.

Xing Liu1,2, Fangjing Rong1,2, Jinhua Tang1,2, Chunchun Zhu1,2, Xiaoyun Chen1,2, Shuke Jia1,2, Zixuan Wang1,2, Xueyi Sun1,2, Hongyan Deng3, Huangyuan Zha1, Gang Ouyang1, Wuhan Xiao4,5,6,7,8.   

Abstract

p53 is a classic tumor suppressor that functions in maintaining genome stability by inducing either cell arrest for damage repair or cell apoptosis to eliminate damaged cells in response to different types of stress. Posttranslational modifications (PTMs) of p53 are thought to be the most effective way for modulating of p53 activation. Here, we show that SIRT5 interacts with p53 and suppresses its transcriptional activity. Using mass spectrometric analysis, we identify a previously unknown PTM of p53, namely, succinylation of p53 at Lysine 120 (K120). SIRT5 mediates desuccinylation of p53 at K120, resulting in the suppression of p53 activation. Moreover, using double knockout mice (p53-/-Sirt5-/-), we validate that the suppression of p53 target gene expression and cell apoptosis upon DNA damage is dependent on cellular p53. Our study identifies a novel PTM of p53 that regulates its activation as well as reveals a new target of SIRT5 acting as a desuccinylase.
© 2021. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34642466      PMCID: PMC8989948          DOI: 10.1038/s41418-021-00886-w

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  61 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  Regulation of p53 localization.

Authors:  S H Liang; M F Clarke
Journal:  Eur J Biochem       Date:  2001-05

Review 3.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

4.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 5.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

Review 6.  Transcriptional and epigenetic regulation of the p53 tumor suppressor gene.

Authors:  Ricardo Saldaña-Meyer; Félix Recillas-Targa
Journal:  Epigenetics       Date:  2011-09-01       Impact factor: 4.528

Review 7.  p53 post-translational modification: deregulated in tumorigenesis.

Authors:  Chao Dai; Wei Gu
Journal:  Trends Mol Med       Date:  2010-11       Impact factor: 11.951

8.  Hsp90 chaperones wild-type p53 tumor suppressor protein.

Authors:  Dawid Walerych; Grzegorz Kudla; Malgorzata Gutkowska; Bartosz Wawrzynow; Lin Muller; Frank W King; Aleksandra Helwak; Joanna Boros; Alicja Zylicz; Maciej Zylicz
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

Review 9.  Targeting mutant p53 for efficient cancer therapy.

Authors:  Vladimir J N Bykov; Sofi E Eriksson; Julie Bianchi; Klas G Wiman
Journal:  Nat Rev Cancer       Date:  2017-12-15       Impact factor: 60.716

Review 10.  Mutant p53 in cancer: new functions and therapeutic opportunities.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

View more
  8 in total

1.  Sex differences resulted differential morbidity and mortality in bladder cancer: smoke, hormone or urobiome?

Authors:  Qi-Dong Xia; Jia Hu; Zheng Liu; Cong Li; Shao-Gang Wang
Journal:  World J Urol       Date:  2021-07-01       Impact factor: 4.226

2.  STOP Codon Mutations at Sites of Natural Caspase Cleavage Are Implicated in Autism and Alzheimer's Disease: The Case of ADNP.

Authors:  Illana Gozes; Shula Shazman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-23       Impact factor: 6.055

3.  Governing glutaminolysis by regulation of glutaminase succinylation.

Authors:  Qingxia Ma; Hongfei Jiang; Leina Ma; Ying Meng; Dong Guo; Yingying Tong; Zhimin Lu
Journal:  Protein Cell       Date:  2021-12-16       Impact factor: 14.870

Review 4.  Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification.

Authors:  Yidian Fu; Jie Yu; Fang Li; Shengfang Ge
Journal:  J Exp Clin Cancer Res       Date:  2022-04-15

Review 5.  Insights on the Modulation of SIRT5 Activity: A Challenging Balance.

Authors:  Matteo Mori; Giulia Cazzaniga; Fiorella Meneghetti; Stefania Villa; Arianna Gelain
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

Review 6.  Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.

Authors:  Francesco Fiorentino; Carola Castiello; Antonello Mai; Dante Rotili
Journal:  J Med Chem       Date:  2022-07-08       Impact factor: 8.039

Review 7.  Oxidative stress and inflammation regulation of sirtuins: New insights into common oral diseases.

Authors:  Zijian Pan; Hao Dong; Ning Huang; Jie Fang
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

Review 8.  Metabolite-derived protein modifications modulating oncogenic signaling.

Authors:  Yawen Liu; Anke Vandekeere; Min Xu; Sarah-Maria Fendt; Patricia Altea-Manzano
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.